Title Issue Date
Molecular response with asciminib 20 mg QD in a patient intolerant to multiple TKIs Stuckey, Ruth; Navarrete Bullon, Laura; Borrero Borrego, Asuncion; Ballester, Violeta Vidal; Rodriguez-Medina, Carlos, et al Issued date: 2025 DOI: 10.1007/s00277-025-06339-5 Source: Annals Of Hematology[ISSN 0939-5555], v. 104, pp. 3007-3009 (Abril 2025) SJR: 0,912 - Q1 JCR: 3,0 - Q2 SCIE MIAR ICDS: 11,0 Artículo
Tyrosine Kinase Inhibitor Treatment of a Patient with Chronic Myeloid Leukemia and Congenital Thrombophilia Herrera-Hernández, Carol; Segura Díaz, Adrian ; Stuckey, Ruth; López Rodríguez, Juan Francisco ; Gómez Casares, María Teresa Issued date: 2025 DOI: 10.3390/hematolrep17050047 Source: Hematology Reports[ISSN 2038-8322],v. 17 (5), (Octubre 2025) SJR: 0,263 - Q4 ESCI MIAR ICDS: 9,6 Artículo
Presence of Myeloid Mutations in Patients with Chronic Myeloid Leukemia Increases Risk of Cardiovascular Event on Tyrosine Kinase Inhibitor Treatment Stuckey, Ruth; Segura Díaz, Adrian ; Sáez Perdomo, María Nieves; Pérez Encinas, Manuel Mateo; González San Miguel, Jóse David, et al Issued date: 2023 DOI: 10.3390/cancers15133384 Source: Cancers [EISSN 2072-6694], v. 15 (13), (Julio 2023) SJR: 1,391 - Q1 JCR: 4,5 - Q1 MIAR ICDS: 10,6 Artículo